MedPath

ARTIDIS AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

Not Applicable
Recruiting
Conditions
Breast Cancer
Interventions
Diagnostic Test: Nanomechanical Phenotype Test
First Posted Date
2023-10-17
Last Posted Date
2024-11-20
Lead Sponsor
ARTIDIS AG
Target Recruit Count
2706
Registration Number
NCT06085833
Locations
🇺🇸

Baylor College of Medicine, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath